Jacobs N, Giannini S L, Doyen J, Baptista A, Moutschen M, Boniver J, Delvenne P
Department of Pathology, University Hospital of Liège, CHU Sart Tilman, Belgium.
Clin Exp Immunol. 1998 Jan;111(1):219-24. doi: 10.1046/j.1365-2249.1998.00437.x.
It has been postulated that an impaired immune response may contribute to the progression of human papillomavirus (HPV)-associated preneoplastic lesions. Based on this hypothesis, we evaluated the cytokine production in the blood of patients with squamous intraepithelial lesions (SIL) of the uterine cervix. The levels of type-1 (interferon-gamma (IFN-gamma) and IL-12) and type-2(IL-4 and IL-10) cytokines were measured in whole blood culture supernatants of patients with low- and high-grade SIL and control women. There was no difference in IL-4 and IFN-gamma levels between patients with SIL and the control group. In contrast, the ratio of IL-12/IL-10 levels was significantly lower in patients with SIL compared with the control group. A lower IL-12/IL-10 ratio in women with SIL was also observed when peripheral blood mononuclear cell (PBMC) culture supernatants and plasma samples were analysed. In patients, neither the lower expression of the CD3epsilon chain nor the higher frequency of HLA-DRB1*1501 expression could be correlated with abnormal cytokine production. These results suggest that a part of the cytokine network, namely IL-10 and IL-12, is perturbed in patients with SIL. A better knowledge of the role of these cytokines in regulating the growth of HPV-associated SIL might have practical implications for the development of vaccines or immunomodulatory strategies in the treatment of cervical cancers.
据推测,免疫反应受损可能会促使人类乳头瘤病毒(HPV)相关的癌前病变进展。基于这一假设,我们评估了子宫颈鳞状上皮内病变(SIL)患者血液中的细胞因子产生情况。在低度和高度SIL患者以及对照女性的全血培养上清液中测量了1型(干扰素-γ(IFN-γ)和IL-12)和2型(IL-4和IL-10)细胞因子的水平。SIL患者与对照组之间的IL-4和IFN-γ水平没有差异。相比之下,与对照组相比,SIL患者的IL-12/IL-10水平比值显著更低。当分析外周血单个核细胞(PBMC)培养上清液和血浆样本时,也观察到SIL女性的IL-12/IL-10比值更低。在患者中,CD3ε链的低表达和HLA-DRB1*1501表达的高频率均与细胞因子产生异常无关。这些结果表明,细胞因子网络的一部分,即IL-10和IL-12,在SIL患者中受到干扰。更好地了解这些细胞因子在调节HPV相关SIL生长中的作用可能对宫颈癌治疗中疫苗或免疫调节策略的开发具有实际意义。